|
|
|
|
Vol. 53, Issue 3, 408-414, March 1998
Centre de Génétique Moléculaire du Centre
National de la Recherche Scientifique, Laboratoire propre associé
à l'Université Pierre et Marie Curie, F91198
Gif-sur-Yvette Cedex, France
The presence of CYP2D6 at the surface of isolated rat and human
hepatocytes and its recognition by autoantibodies were reported recently. We wondered whether the unexpected outside orientation at the
plasma membrane could be related to topological inversion (luminal-oriented form) of cytochrome P450 in the endoplasmic reticulum. To examine the potential role of cDNA polymorphism, a CYP2D6
variant carrying three positive charges at the amino terminus (2D6ext)
was constructed and expressed in yeast. Immunoblotting, flow cytometry,
and electron microscopy showed that wild-type CYP2D6 expressed in yeast
was present on the outer face of the cell plasma membrane in addition
to the regular microsomal location. This location reproduces the
hepatocyte situation. 2D6ext expressed in yeast and COS7 cells seemed
to be partially N-glycosylated and was located at the
plasma membrane surface. Nevertheless, the glycosylated form was not
enriched in the plasma membranes compared with microsomes. The
relationship between CYP2D6 and 2D6ext topologies and catalytic
competence was tested. Cumene hydroperoxide-dependent dextromethorphan
demethylation was performed on microsomal vesicles after combined
proteolysis and immunoinhibition experiments. CYP2D6 activity was
completely abolished, whereas the glycosylated and luminal-oriented
fraction of 2D6ext remained active. This suggests that a
luminal-oriented glycosylated form is not involved in cytochrome P450
transport to the plasma membrane. Yeast thus reproduces the unusual
CYP2D6 plasma membrane location and orientation, which do not require
sequence alteration, glycosylation, or even an inverted endoluminal
orientation.
This article has been cited by other articles:
![]() |
M. Maibeche-Coisne, A. A. Nikonov, Y. Ishida, E. Jacquin-Joly, and W. S. Leal Pheromone anosmia in a scarab beetle induced by in vivo inhibition of a pheromone-degrading enzyme PNAS, August 3, 2004; 101(31): 11459 - 11464. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cotman, D. Jezek, K. F. Tacer, R. Frangez, and D. Rozman A Functional Cytochrome P450 Lanosterol 14{alpha}-Demethylase CYP51 Enzyme in the Acrosome: Transport through the Golgi and Synthesis of Meiosis-Activating Sterols Endocrinology, March 1, 2004; 145(3): 1419 - 1426. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-A. Robin, V. Descatoire, M. Le Roy, A. Berson, F.-P. Lebreton, M. Maratrat, F. Ballet, J. Loeper, and D. Pessayre Vesicular Transport of Newly Synthesized Cytochromes P4501A to the Outside of Rat Hepatocyte Plasma Membranes J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1063 - 1069. [Abstract] [Full Text] |
||||
![]() |
V. De Berardinis, C. Moulis, M. Maurice, P. Beaune, D. Pessayre, D. Pompon, and J. Loeper Human Microsomal Epoxide Hydrolase Is the Target of Germander-Induced Autoantibodies on the Surface of Human Hepatocytes Mol. Pharmacol., September 1, 2000; 58(3): 542 - 551. [Abstract] [Full Text] |
||||
![]() |
J. Loeper, B. Louérat-Oriou, C. Duport, and D. Pompon Yeast Expressed Cytochrome P450 2D6 (CYP2D6) Exposed on the External Face of Plasma Membrane Is Functionally Competent Mol. Pharmacol., July 1, 1998; 54(1): 8 - 13. [Abstract] [Full Text] |
||||
![]() |
E. P. A. Neve and M. Ingelman-Sundberg Molecular Basis for the Transport of Cytochrome P450 2E1 to the Plasma Membrane J. Biol. Chem., May 26, 2000; 275(22): 17130 - 17135. [Abstract] [Full Text] [PDF] |
||||